Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Alto Neuroscience, Inc. ("Alto") , a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a favorable ...

MANN, the test developed at OHSU could help save lives Jared Fischer, Ph.D., left, and Jose Luis Montoya Mira, Ph.D., cancer ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, which provides additional clinical validation of Esopredict®, the only ...

As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million ...

Many children with food allergies experience psychosocial burdens associated with food-allergy related bullying and anxiety "Our study findings highlight that it is important for allergists and ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

China has reported two more H9N2 avian flu infections in humans, both of them patients from Hunan province in the southern ...

Two more illnesses have been reported in Uganda's Ebola Sudan outbreak, raising the outbreak total to nine, according to a ...

Industry insiders and researchers say the industry is riddled with loopholes that allow consumers to be deceived about everything from the marijuana’s potency, to the prevalence of dangerous ...